TY - JOUR T1 - Public opinion on a mandatory COVID-19 vaccination policy in France: a cross sectional survey JF - medRxiv DO - 10.1101/2021.07.05.21260017 SP - 2021.07.05.21260017 AU - Amandine Gagneux-Brunon AU - Elisabeth Botelho-Nevers AU - Marion Bonneton AU - Patrick Peretti-Watel AU - Pierre Verger AU - Odile Launay AU - Jeremy K. Ward Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/11/02/2021.07.05.21260017.abstract N2 - Objectives Reaching the last pockets of unvaccinated people is challenging, and has led to consider COVID-19 mandatory vaccination. Our aim was to assess attitudes toward COVID-19 mandatory vaccination in France before the announcement and factors associated with opposition to this type of policy.Methods Between the 10th and the 23rd of May 2021, we conducted a cross-sectional online survey among a representative sample of the French population aged 18 and over and a specific sample of the French Senior Population over 65.Results Among 3,056 respondents, 1,314 (43.0 %) were in favor of mandatory COVID-19 vaccination, 1,281 (41.9 %) were opposed to such a policy, and 461 (15.1 %) were undecided. Among opponents to COVID-19 mandatory vaccination for the general population, 385 (30.05 %) were in favor of a mandatory COVID-19 vaccination for healthcare workers (HCWs). In multivariate analysis, age groups 18-24 years, and 25-34 years were significantly more opposed than the reference group (>75 years old) with respective adjusted odds ratio (aOR) and 95 % confidence interval (95 % CI) 4.67 (1.73-12.61) and 3.74 (1.57-8.93). No intention of getting COVID-19 vaccine was strongly associated with opposition to mandatory vaccination with aOR 10.67 (95 % CI 6.41-17.76). In comparison with partisans of the center, partisans of the far left and green parties were more likely to be opposed to COVID-19 mandatory vaccine with respective aOR (95 % CI) 1;89 (1.06-3.38) and 2.08 (1.14-3.81).Conclusion Attitudes toward mandatory COVID-19 vaccination are split in the French general population, and the debate might become politicized.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was carried out within the COVIREIVAC platform (intended for COVID-19 vaccine clinical research) and received financial support from INSERM, the Ministry of Health, and The Ministry of Higher Education and Research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study design was approved by the ethical committee of the University Hospital Institute Mediterranee Infection (#2021 001).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available by request to the corresponding author. ER -